Additionally, two studies have found that the inhibition of IGF1R can lead to significant improvements in lifespan and alleviate symptoms in mouse models of spinal muscular atrophy and Alzheimer's disease 64, 65. Here, IGF1R is linked to early-onset autosomal dominant Alzheimer disease.